Several mechanisms have been proposed for diabetic nephropathy progression and development, including lipid disorders, oxidative stress, pro-fibrotic and fibrotic cytokines generation (such as fibronectin (FN)-1, plasminogen activator inhibitor (PAI)-1, and connective tissue growth factor (CTGF) [163–166]. This evidence concerns the gene FN1 and diabetic kidney disease.